FeesSafety
Pluang+

MediPharm Labs launches ANVISA-approved CBD oil in Brazil, expanding its medical cannabis market presence.

Market News
11 Nov 2026, 01:00 WIB
GlobeNewsWire
View Source
Bullish
MediPharm Labs launches ANVISA-approved CBD oil in Brazil, expanding its medical cannabis market presence.

MediPharm Labs has commercially launched a full-spectrum CBD oral oil in Brazil through its partner Alko do Brasil, following ANVISA authorization. The product is manufactured at MediPharm's GMP-certified facility in Canada and meets Brazil's strict regulatory standards. This launch marks a significant step in MediPharm's international growth strategy, tapping into Brazil's fast-growing medical cannabis market, estimated at C$2.58 billion. The product is now available by prescription in Brazilian pharmacies, supporting patient access to regulated cannabinoid therapies.

MediPharm Labs' expansion in Brazil provides context for the health sector's performance on Pluang. As of Nov 11, 2026 04:52 WIB, 49 of 150 priced US health stocks rose while 100 fell. Notable movers include HIMS at USD 19.00 with a 1-day change of -17.18%, WGS at USD 55.15 down 16.08%, and INO at USD 1.30 down 13.91%.

More News

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...

Company Fundamentals
Bullish
2 hours ago
Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...

Others
Bullish
2 hours ago
TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...

Company Fundamentals
Bullish
2 hours ago
Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
4 hours ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App